4486 related articles for article (PubMed ID: 6792293)
1. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma.
García-Borrón JC; Martinez JH; Arocas A; Solano F; Vicente V; Gómez S; Iborra JL; Lozano JA
Int J Biochem; 1985; 17(9):995-1002. PubMed ID: 3934011
[TBL] [Abstract][Full Text] [Related]
3. Transfer of tyrosinase to melanosomes in Harding-Passey mouse melanoma.
Tomita Y; Hariu A; Kato C; Seiji M
Arch Biochem Biophys; 1983 Aug; 225(1):75-85. PubMed ID: 6412634
[TBL] [Abstract][Full Text] [Related]
4. Characterization of structural properties for morphological differentiation of melanosomes: II. Electron microscopic and SDS-PAGE comparison of melanosomal matrix proteins in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1982 Jan; 78(1):76-81. PubMed ID: 7054310
[TBL] [Abstract][Full Text] [Related]
5. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
Yamamoto H; Takeuchi T
J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
[TBL] [Abstract][Full Text] [Related]
6. Characterization of structural properties for morphologic differentiation of melanosomes. III. free and protein-bound dopa and 5-S-cysteinyldopa in B16 and Harding-Passey melanomas.
Ito S; Homma K; Kiyota M; Fujita K; Jimbow K
J Invest Dermatol; 1983 Mar; 80(3):207-9. PubMed ID: 6402551
[TBL] [Abstract][Full Text] [Related]
7. Activation of tyrosinase in microsomes and melanosomes from B16 and Harding-Passey melanomas.
Menon IA; Haberman HF
Arch Biochem Biophys; 1970 Mar; 137(1):231-42. PubMed ID: 4985092
[No Abstract] [Full Text] [Related]
8. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
Miranda M; Botti D
Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
[TBL] [Abstract][Full Text] [Related]
9. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
Imokawa G; Mishima Y
Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
[TBL] [Abstract][Full Text] [Related]
11. Microheterogeneity of melanosome-bound tyrosinase from the Harding-Passey murine melanoma.
Ferrini U; Mileo AM; Hearing VJ
Int J Biochem; 1987; 19(3):227-34. PubMed ID: 3109972
[TBL] [Abstract][Full Text] [Related]
12. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
Tomita Y; Moro S; Seiji M
J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
[No Abstract] [Full Text] [Related]
13. Aggregation equilibria of tyrosinase of Harding-Passey mouse melanoma.
Garcia-Borron JC; Solano F; Iborra JL; Lozano JA
Biochem J; 1985 May; 228(1):95-101. PubMed ID: 3924035
[TBL] [Abstract][Full Text] [Related]
14. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
Imokawa G; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
[No Abstract] [Full Text] [Related]
15. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
Kageshita T; Ono T; Arao T; Tomita Y
Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
[No Abstract] [Full Text] [Related]
16. Ultrasonic measurement of melanosomes for characterization of their physicochemical structure in B16 and Harding-Passey melanomas.
Kono R; Jimbow K; Takahashi H; Maeda K
Cancer Res; 1984 Oct; 44(10):4337-41. PubMed ID: 6467195
[TBL] [Abstract][Full Text] [Related]
17. Characterization of biochemical properties of melanosomes for structural and functional differentiation: analysis of the compositions of lipids and proteins in melanosomes and their subfractions.
Jimbow M; Kanoh H; Jimbow K
J Invest Dermatol; 1982 Aug; 79(2):97-102. PubMed ID: 7097043
[TBL] [Abstract][Full Text] [Related]
18. The tyrosinase activity of melanosomes from the Harding-Passey melanoma: the absence of a peroxidase component in vitro.
Mufson RA
Arch Biochem Biophys; 1975 Apr; 167(2):738-43. PubMed ID: 804863
[No Abstract] [Full Text] [Related]
19. Half-lives of tyrosinase isozymes from Harding-Passey mouse melanoma.
Martinez JH; Solano F; Peñafiel R; Lozano JA
Cancer Lett; 1988 Jan; 38(3):339-46. PubMed ID: 3127037
[TBL] [Abstract][Full Text] [Related]
20. Enhanced melanization of Harding-Passey mouse melanoma cells following treatment with exogenous melanosomes in monolayer culture.
Leising HB; Schachtschabel DO
Z Naturforsch C Biosci; 1979; 34(1-2):124-30. PubMed ID: 155942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
